Veristat Acquires SFL (Solutions for Life Sciences)
March 7, 2022
Veristat, a scientific-focused global CRO headquartered in Southborough, Massachusetts, has acquired SFL (Solutions for Life Sciences), a Basel-based multi-disciplinary life sciences consultancy. The acquisition expands Veristat's regulatory affairs, pharmacovigilance, medical writing, market access and quality assurance capabilities in Europe and strengthens its ability to support biopharma and medtech clients entering EU/UK/Swiss markets.
- Buyers
- Veristat
- Targets
- SFL (Solutions for Life Sciences)
- Industry
- Healthcare Services
- Location
- Basel-Stadt, Switzerland
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Verista Acquires ILB Enterprises
May 31, 2024
Healthcare Services
Verista has acquired ILB Enterprises, a New Jersey–based life sciences consulting firm specializing in pharmacovigilance, safety compliance, program and project management. The deal, led by Verista's private equity sponsor Lightview Capital, expands Verista's capabilities across compliance, automation and validation and strengthens its Mid‑Atlantic life sciences services footprint.
-
Veristat Acquires Instat Clinical Research
October 19, 2023
Healthcare Services
Veristat, a full-service clinical research organization, has acquired Instat Clinical Research, a biometrics-focused CRO with teams in the United States and India. The deal expands Veristat's biometrics, data management, biostatistics, and statistical programming capabilities while adding offshore capacity to enable round-the-clock support for clinical studies.
-
Veristat Acquires SQN Clinical
February 25, 2021
Healthcare Services
Veristat acquired SQN Clinical to expand its biometrics capabilities and strengthen its European footprint. The acquisition adds more than 80 employees and integrates SQN Clinical's clinical data management, biostatistics and project management capabilities into Veristat's global CRO services.
-
BioLife Solutions Acquires SciSafe
September 21, 2020
Healthcare Services
BioLife Solutions, Inc. (NASDAQ: BLFS) has entered into a definitive agreement to acquire SciSafe, a privately held multi-facility biostorage provider serving the cell and gene therapy and pharmaceutical industries. BioLife will pay $15 million cash and $15 million in newly issued BioLife common shares for 100% of SciSafe, with up to 626,000 additional shares earnable based on revenue milestones; the deal is expected to close on September 30.
-
In Vitro Sciences (Sverica) Partners with InVia Fertility Specialists
August 26, 2020
Healthcare Services
In Via Fertility Specialists has entered a partnership with In Vitro Sciences, a portfolio company of Sverica Capital Management, with Dresner Partners advising InVia on the transaction. InVia — a four-location fertility clinic group in the Chicagoland area with an on-site embryology lab and three reproductive endocrinologists — will gain strategic, operational and financial resources to support growth and enhance patient care.
-
Veristat Acquires The Clinical Trial Company Ltd (TCTC Group)
January 6, 2020
Healthcare Services
Veristat, a full-service CRO based in Southborough, Massachusetts, has acquired The Clinical Trial Company Ltd (TCTC Group), a Europe-headquartered contract research organization. The deal expands Veristat's European footprint and adds TCTC's expertise in gene and cell therapy, CNS and orphan disease clinical trials to Veristat's service offering.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.